Search

Issue
Title
Authors
Vol 23, No 4 (2021)
Endoscopic esophageal stenting in combination with chemoradiation therapy: A review
Ivanov A.I., Popov V.A., Burmistrov M.V.
PDF
(Rus)
Vol 23, No 1 (2021)
Treatment of advanced small cell lung cancer. Clinical case and literature review
Menshikov K.V., Sultanbaev A.V., Musin S.I., Menshikova I.A., Nasretdinov A.F., Sultanbaeva N.I.
PDF
(Rus)
Vol 21, No 3 (2019)
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
PDF
(Rus)
Vol 20, No 1 (2018)
The role of cytoreduction surgery in advanced ovarian cancer (review)
Tandelov R.K., Sel'chuk V.Y., Morkhov K.Y., Nechushkina V.M., Kuznetsov V.V.
PDF
(Rus)
Vol 17, No 2 (2015)
The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
Motalkina M.S., Kulyova S.A., Alexeev S.M., Zuzgin I.S., Filatova L.V., Zhabina A.S., Zverkova A.A., Ishmatova I.V., Rjazankina A.A., Artemyeva A.S., Semiglazova T.Y.
Vol 16, No 1 (2014)
New chemotherapy options for triple-negative breast cancer (review of literature)
Sekundova M.A., Zdvizhkov A.M., Borisov V.I.
Vol 11, No 3 (2009)
Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
Zhukova L.G., Abramov M.E., Vakhabova Y.V., Lud A.N., Obukhov A.A., Lichinitser M.R.
Vol 11, No 1 (2009)
Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
Zhukova L.G.
Vol 10, No 3 (2008)
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy
Besova N.S., Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Vol 9, No 4 (2007)
Rezul'taty lecheniya Myustoforanom rasprostranennoy i metastaticheskoy form melanomy
Radyukova I.M., Kosenok V.K., Tarasevich A.D., Merkulov V.N., Kurakin V.I., Trenina N.A.
Vol 8, No 4 (2006)
Limfoma Khodzhkina: prognosticheskie priznaki segodnya
Demina E.A.
Vol 8, No 1 (2006)
Dopolnitel'nye kliniko-laboratornye faktory prognoza pri diffuznoy krupnokletochnoy V-kletochnoy limfome
Babicheva L.G., Poddubnaya I.V.
Vol 7, No 2 (2005)
Farmorubitsin v klinicheskoy praktike
Gorbunova V.A.
Vol 25, No 4 (2023)
Dermatological toxicity in the treatment of malignant tumors in children: A review
Belysheva T.S., Shatokhina E.A., Komarova A.D.
PDF
(Rus)
Vol 25, No 1 (2023)
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
PDF
(Rus)
Vol 23, No 4 (2021)
Features of response to modern neoadjuvant chemotherapy with dual anti-HER2 blockade (trastuzumab and pertuzumab) in the patients with HER2-positive breast cancer stage II–III
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Ganshina I.P., Khokhlova S.V., Kоmetova V.V., Rodionov V.V.
PDF
(Rus)
Vol 23, No 1 (2021)
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N.I., Vladimirova L.I., Kolyadina I.V., Frantsiyants E.M., Storozhakova A.E., Bandovkina V.A., Kalabanova E.A., Kabanov S.N., Svetitskaya I.V., Tishina A.V., Ezhova M.O.
PDF
(Rus)
Vol 21, No 3 (2019)
The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer
Gordeeva O.O., Kolyadina I.V., Zhukova L.G., Gan'shina I.P., Komov D.V., Meshcheriakov A.A.
PDF
(Rus)
Vol 19, No 3 (2017)
Diagnosis and treatment of malignant trophoblastic tumors: errors, dangers, complications (review of the literature)
Gasanbekova Z.A., Aliev S.A., Meshcheryakova L.A., Kozachenko V.P., Kuznetsov V.V.
PDF
(Rus)
Vol 17, No 4 (2015)
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.A.
Vol 15, No 3 (2013)
Opyt primeneniya Votrienta v kombinirovannom lechenii redkikh mestno-rasprostranennykh sarkom myagkikh tkaney vysokoy stepeni zlokachestvennosti
Zubarev A.L., Kuril'chik A.A., Starodubtsev A.L., Ivanov V.E.
Vol 11, No 3 (2009)
Klinicheskiy sluchay effektivnogo lecheniya lapatinibom (Tayverb)i kapetsitabinom (Kseloda) bol'noy disseminirovannym rakom molochnoy zhelezy s giperekspressiey ErbB2 (Her-2/neu) s metastaticheskim porazheniem veshchestva i obolochek golovnogo mozga
Naskhletashvili D.R., Chmutin G.E.
Vol 10, No 4 (2008)
Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey
Rasner P.I., Pushkar' D.Y., Govorov A.V.
Vol 10, No 3 (2008)
Samoe masshtabnoe sravnitel'noe issledovanie III fazy iz vsekh ranee opublikovannykh pokazalo, chto IRESSATM (gefitinib) tak zhe effektivna, kak i dotsetaksel u patsientov s rasprostranennym nemelkokletochnym rakom legkogo posle neudachi predshestvuyushchey terapii
Vol 10, No 1 (2008)
Ad\"yuvantnoe lechenie raka tolstoy kishki
Artamonova E.V., Podregul'skiy K.E.
Vol 8, No 1 (2006)
Klinicheskiy opyt primeneniya zomety u bol'nykh mnozhestvennoy mielomoy (rezul'taty Rossiyskogo mnogotsentrovogo issledovaniya)
Votyakova O.M., Khoroshko N.D., Zhuravlev V.S., Shamray V.S., Korobkin V.A., Shelekhova N.M.
Vol 8, No 1 (2006)
Limfoma iz kletok mantiynoy zony: klinicheskie osobennosti i vozmozhnosti terapii
Lorie Y.Y.
Vol 7, No 2 (2005)
Astrotsitomy nizkoy stepeni zlokachestvennosti polushariy bol'shogo mozga
Aleshin V.A., Karakhan V.B.
101 - 128 of 128 Items << < 1 2 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"